It is a healthcare private limited company based in Chennai, Tamil Nadu, India, established in 2015.
2015 | Chennai, Tamil Nadu, India | ActivePriomed Life Sciences Private Limited, a active private limited company, was established on 06 January 2015 in Chennai, Tamil Nadu, India. Engaging in medical equipment retail & distribution within the trade sector, it holds CIN: U74900TN2015PTC098727. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹0.20 M and a paid-up capital of ₹0.12 M.
It upholds a compliant status. Its leadership includes Ansar Basha Mansoor Basha (Director), Ganapathy Girirajan (Director), Abdulhameed Kather Ismail (Director). Past directors included Ramalingam Nandakumar, Perumalsamy Ramadas, Ethirajulu Senthil Nathan. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at No.3, First Floor, 11Th Street, Surendra Nagar Adambakkam, Chennai, Tamil Nadu, 600088.
U74900TN2015PTC098727
098727
06 January 2015
₹0.20 M
₹0.12 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Priomed Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ansar Basha Mansoor Basha | Director | 06 Jan 2015 | Current |
| Ganapathy Girirajan | Director | 06 Jan 2015 | Current |
| Abdulhameed Kather Ismail | Director | 27 Sep 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 16 Mar 2016 | Past |
| Pramod Abcsdd | Director | 16 Mar 2016 | Past |
| Pramod Abcsdd | Director | 16 Sep 2015 | Past |
| Pramod Abcsdd | Director | 31 Jan 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Priomed Life Sciences Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 33.61% increase. The company also saw a substantial improvement in profitability, with a 119.73% increase in profit. The company's net worth Soared by an impressive increase of 18.67%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Priomed Life Sciences had a promoter holding of 75.00% and a public holding of 25.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Priomed Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Priomed Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Priomed Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Priomed Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
Priomed Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai. was recorded as a recent event.
The activity Abdulhameed Kather Ismail was appointed as a Director was appointed as a Director on 27 Sep 2016 & has been associated with this company since 9 years 2 months . was completed.
The activity Ansar Basha Mansoor Basha was appointed as a Director was appointed as a Director on 06 Jan 2015 & has been associated with this company since 10 years 11 months . was completed.
The activity Ganapathy Girirajan was appointed as a Director was appointed as a Director on 06 Jan 2015 & has been associated with this company since 10 years 11 months . was completed.
The activity Priomed Life Sciences Private Limited was registered on 06 Jan 2015 with Roc Chennai & aged 10 years 11 months as per MCA records. was completed.
The CIN of Priomed Life Sciences Private Limited is U74900TN2015PTC098727.
Priomed Life Sciences Private Limited is headquartered at No.3, First Floor, 11Th Street, Surendra Nagar Adambakkam, Chennai, Tamil Nadu, 600088.
Priomed Life Sciences Private Limited was incorporated on 06 January 2015.
The current directors of Priomed Life Sciences Private Limited are
The primary industry of Priomed Life Sciences Private Limited is Trade.
Priomed Life Sciences Private Limited is unlisted.
The authorized capital of Priomed Life Sciences Private Limited is ₹0.20 M, and the paid-up capital is ₹0.12 M.
The compliance status of Priomed Life Sciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX